Pasar al contenido principal

SELECTIVA VULNERABILIDAD ESTRIATAL EN LA ENFERMEDAD DE HUNTINGTON: ¿UN PROBLEMA EN LA MITOFAGIA TRANSCELULAR?.

PID2021-123732OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Restoration of CB1 receptor function in hippocampal GABAergic neurons rescues memory deficits in Huntington's disease models

  • Franco, Nadia Di
  • Bengoetxea de Tena, Iker
  • Sanchez-Ruiz, Andrea
  • Pereda-Velarde, Alba
  • Enfedaque, Ferran
  • González-Arias, Candela
  • Miquel-Rio, Lluis
  • Bortolozzi, Analía
  • Rodríguez-Puertas, Rafael
  • Costas-Insua, Carlos
  • Molina-Porcel, Laura
  • Vázquez-Oliver, Anna
  • Ozaita Mintegui, Andrés, 1969-
  • Guzmán, Manuel
  • Perea, Gertrudis
  • Ginés, Silvia
Background: Dysregulation of the endocannabinoid system (eCBS) and the loss of CB1 receptors (CB1R) in the basal ganglia are well-established hallmarks of Huntington's disease (HD). As a result, significant research efforts have focused on targeting the eCBS to alleviate motor disturbances associated with the disease. Beyond its role in motor control, the eCBS is a complex signaling network critically involved in regulating learning and memory. Despite this, the potential involvement of eCBS dysfunction in the cognitive decline characteristic of HD, often manifested well before motor dysfunction, has remained largely unexplored. Methods: CB1R expression in the hippocampus was evaluated in both human HD samples and HD mouse models (R6/1 and Hdh models, including both sexes) using Western blotting, immunohistochemistry, and radioligand binding assays. To restore CB1R function, CB1R agonist WIN-55212-2 was systemically administered, or viral vectors encoding CB1R were locally infused into the hippocampus of HD mice. A multidisciplinary approach combining behavioral, biochemical, electrophysiological, and morphological analyses, was employed to investigate the molecular mechanisms underlying the effects of CB1R activation in the context of HD-related cognitive dysfunction. Results: In both human HD samples and HD mouse models, CB1R protein levels were reduced in the hippocampus, accompanied by structural synaptic alterations and impairment in spatial, recognition and working memory. Moreover, hippocampal depolarization-induced suppression of inhibition was significantly disrupted in R6/1 mice. Administration of WIN-55212-2 successfully restored these synaptic and cognitive deficits. Immunohistochemical analysis revealed that the CB1R decrease was specifically localized to GABAergic interneurons within the hippocampus. Notably, targeted restoration of CB1R expression in these interneurons via viral vector delivery was sufficient to rescue hippocampal-dependent memory deficits in HD mice. Conclusion: This study suggests that impaired CB1R function in hippocampal GABAergic interneurons contributes to memory dysfunction in HD., This work was supported by the Spanish Ministerio de Ciencia e Innovación (PID2021-123732OB-I00 to SG, PID2021-125118OB-I00 to MG, PID2019-106579RB-I00, and PID2022-142617NB-I00 to GP, and PID2022-141700OB-I00 to AB funded by MCIN/AEI/ https://doi.org/10.13039/501100011033). Fundació la Marató de TV3 (202013-30-31-32 to SG, MG and GP), AGAUR Generalitat de Catalunya (2021-SGR-01358 to AB and 2021-SGR 01086 to SG) and grants to R. R.-P. rom the Basque Government IT1454-22 to the "Neurochemistry and Neurodegeneration" consolidated research group; Instituto de Salud Carlos III through the project PI20/00153 (co-funded by European Regional Development Fund "A way to make Europe") and by BIOEF through the project BIO22/ALZ/010 funded by Eitb Maratoia. A P-V is the recipient of a PRE2022-101764 fellowship (PID2021-123732OB-I00). I.B.d.T. is the recipient of an Investigo fellowship funded by the European Union-Next Generation EU.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Restoration of CB1 receptor function in hippocampal GABAergic neurons rescues memory deficits in Huntington's disease models

  • Di Franco, Nadia
  • Bengoetxea de Tena, Iker
  • Sanchez-Ruiz, Andrea
  • Pereda-Velarde, Alba
  • Enfedaque, Ferran
  • Gónzalez-Arias, Candela
  • Rio, Lluis Maria Miquel
  • Bortolozzi, Analía
  • Rodriguez-Puertas, Rafael
  • Costas-Insua, Carlos
  • Molina-Porcel, Laura
  • Vazquez-Oliver, Anna
  • Ozaita, Andres
  • Guzmán, Manuel
  • Perea, Gertrudis
  • Ginés, Silvia
Dysregulation of the endocannabinoid system (eCBS) and the loss of CB1 receptors (CB1R) in the basal ganglia are well-established hallmarks of Huntington's disease (HD). As a result, significant research efforts have focused on targeting the eCBS to alleviate motor disturbances associated with the disease. Beyond its role in motor control, the eCBS is a complex signaling network critically involved in regulating learning and memory. Despite this, the potential involvement of eCBS dysfunction in the cognitive decline characteristic of HD, often manifested well before motor dysfunction, has remained largely unexplored., This work was supported by the Spanish Ministerio de Ciencia e Innovación (PID2021-123732OB-I00 to SG, PID2021-125118OB-I00 to MG, PID2019-106579RB-I00, and PID2022-142617NB-I00 to GP, and PID2022-141700OB-I00 to AB funded by MCIN/AEI/ https://doi.org/10.13039/501100011033). Fundació la Marató de TV3 (202013-30-31–32 to SG, MG and GP), AGAUR Generalitat de Catalunya (2021-SGR-01358 to AB and 2021-SGR 01086 to SG) and grants to R. R.-P. from the Basque Government IT1454-22 to the “Neurochemistry and Neurodegeneration” consolidated research group; Instituto de Salud Carlos III through the project PI20/00153 (co-funded by European Regional Development Fund “A way to make Europe”) and by BIOEF through the project BIO22/ALZ/010 funded by Eitb Maratoia. A P-V is the recipient of a PRE2022-101764 fellowship (PID2021-123732OB-I00). I.B.d.T. is the recipient of an Investigo fellowship funded by the European Union-Next Generation EU., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Restoration of CB1 receptor function in hippocampal GABAergic neurons rescues memory deficits in Huntington's disease models

  • Franco, Nadia Di
  • Bengoetxea de Tena, Iker
  • Sanchez-Ruiz, Andrea
  • Pereda-Velarde, Alba
  • Enfedaque, Ferran
  • González-Arias, Candela
  • Miquel-Rio, Lluis
  • Bortolozzi, Analía
  • Rodríguez-Puertas, Rafael
  • Costas-Insua, Carlos
  • Molina-Porcel, Laura
  • Vázquez-Oliver, Anna
  • Ozaita Mintegui, Andrés, 1969-
  • Guzmán, Manuel
  • Perea, Gertrudis
  • Ginés, Silvia
Background: Dysregulation of the endocannabinoid system (eCBS) and the loss of CB1 receptors (CB1R) in the basal ganglia are well-established hallmarks of Huntington's disease (HD). As a result, significant research efforts have focused on targeting the eCBS to alleviate motor disturbances associated with the disease. Beyond its role in motor control, the eCBS is a complex signaling network critically involved in regulating learning and memory. Despite this, the potential involvement of eCBS dysfunction in the cognitive decline characteristic of HD, often manifested well before motor dysfunction, has remained largely unexplored. Methods: CB1R expression in the hippocampus was evaluated in both human HD samples and HD mouse models (R6/1 and Hdh models, including both sexes) using Western blotting, immunohistochemistry, and radioligand binding assays. To restore CB1R function, CB1R agonist WIN-55212-2 was systemically administered, or viral vectors encoding CB1R were locally infused into the hippocampus of HD mice. A multidisciplinary approach combining behavioral, biochemical, electrophysiological, and morphological analyses, was employed to investigate the molecular mechanisms underlying the effects of CB1R activation in the context of HD-related cognitive dysfunction. Results: In both human HD samples and HD mouse models, CB1R protein levels were reduced in the hippocampus, accompanied by structural synaptic alterations and impairment in spatial, recognition and working memory. Moreover, hippocampal depolarization-induced suppression of inhibition was significantly disrupted in R6/1 mice. Administration of WIN-55212-2 successfully restored these synaptic and cognitive deficits. Immunohistochemical analysis revealed that the CB1R decrease was specifically localized to GABAergic interneurons within the hippocampus. Notably, targeted restoration of CB1R expression in these interneurons via viral vector delivery was sufficient to rescue hippocampal-dependent memory deficits in HD mice. Conclusion: This study suggests that impaired CB1R function in hippocampal GABAergic interneurons contributes to memory dysfunction in HD., This work was supported by the Spanish Ministerio de Ciencia e Innovación (PID2021-123732OB-I00 to SG, PID2021-125118OB-I00 to MG, PID2019-106579RB-I00, and PID2022-142617NB-I00 to GP, and PID2022-141700OB-I00 to AB funded by MCIN/AEI/ https://doi.org/10.13039/501100011033). Fundació la Marató de TV3 (202013-30-31-32 to SG, MG and GP), AGAUR Generalitat de Catalunya (2021-SGR-01358 to AB and 2021-SGR 01086 to SG) and grants to R. R.-P. rom the Basque Government IT1454-22 to the "Neurochemistry and Neurodegeneration" consolidated research group; Instituto de Salud Carlos III through the project PI20/00153 (co-funded by European Regional Development Fund "A way to make Europe") and by BIOEF through the project BIO22/ALZ/010 funded by Eitb Maratoia. A P-V is the recipient of a PRE2022-101764 fellowship (PID2021-123732OB-I00). I.B.d.T. is the recipient of an Investigo fellowship funded by the European Union-Next Generation EU.